T 0012/01 (Lactoferrin/BAYLOR COLLEGE OF MEDICINE) of 02.12.2003
- European Case Law Identifier
- ECLI:EP:BA:2003:T001201.20031202
- Date of decision
- 2 December 2003
- Case number
- T 0012/01
- Petition for review of
- -
- Application number
- 90907718.2
- IPC class
- C12N 15/12
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Human Lactoferrin cDNA Sequence
- Applicant name
- BAYLOR COLLEGE OF MEDICINE
- Opponent name
- Pharming Group NV
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2) 1973European Patent Convention Art 54 1973European Patent Convention Art 56 1973European Patent Convention Art 83 1973European Patent Convention Art 87 1973European Patent Convention R 88 1973
- Keywords
- Main request: added matter (no)
Sufficiency of disclosure (yes)
Entitlement to priority date (yes)
Novelty (yes)
Inventive step (yes) - Catchword
- -
- Citing cases
- T 1057/09
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to maintain the patent on the basis of the claims of the main request filed on 28 February 2001 for all designated Contracting States except ES and corresponding claims for the Contracting State ES filed during the oral proceedings, and the description and drawings as granted.